Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment

Published:2023-11-27 Issue:3 Volume:15 Page:154-161
ISSN:2651-2653
Container-title:Ulusal Romatoloji Dergisi
language:
Short-container-title:raed

Author:

Kaymaz Tahra Sema^ORCID,Alibaz-Öner Fatma^ORCID,Kaplan Taylan^ORCID,Yalçınkaya Yasemin^ORCID,İnanç Nevsun^ORCID,Atagündüz Mehmet Pamir^ORCID,Barutcu Ataş Dilek^ORCID,Aşıcıoğlu Ebru^ORCID,Serhan Tuğlular Zübeyde^ORCID,Direskeneli Haner^ORCID

Publisher

Galenos Yayinevi

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference40 articles.

1. Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years;Aguiar;Arthritis Care Res (Hoboken),2017

2. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study;Dass;Ann Rheum Dis,2008

3. Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases;Md Yusof;Arthritis Rheumatol,2019

4. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis;Buch;Ann Rheum Dis,2011

5. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis;Chung;Arthritis Rheumatol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP